Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The ecosystem of health decision making: from fragmentation to synergy
Holger J. Schünemann, Marge Reinap, Thomas Piggott, et al.
The Lancet Public Health (2022) Vol. 7, Iss. 4, pp. e378-e390
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

The development methods of official GRADE articles and requirements for claiming the use of GRADE – A statement by the GRADE guidance group
Holger J. Schünemann, Sue Brennan, Elie A. Akl, et al.
Journal of Clinical Epidemiology (2023) Vol. 159, pp. 79-84
Open Access | Times Cited: 76
GRADE guidance 39: using GRADE-ADOLOPMENT to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses
Miloslav Klugar, Tamara Lotfi, Andrea Darzi, et al.
Journal of Clinical Epidemiology (2024) Vol. 174, pp. 111494-111494
Closed Access | Times Cited: 8
Uptake of orphan drugs in the WHO essential medicines lists
Enrico Costa, Lorenzo Moja, Veronika J. Wirtz, et al.
Bulletin of the World Health Organization (2024) Vol. 102, Iss. 1, pp. 22-31
Open Access | Times Cited: 7
Cancer medicines on the WHO Model List of Essential Medicines: processes, challenges, and a way forward
Kristina Jenei, Zeba Aziz, Christopher M. Booth, et al.
The Lancet Global Health (2022) Vol. 10, Iss. 12, pp. e1860-e1866
Open Access | Times Cited: 34
Financing and Reimbursement of Approved Advanced Therapies in Several European Countries
Carolina Iglesias-López, Antònia Agustí, Antonio Vallano, et al.
Value in Health (2023) Vol. 26, Iss. 6, pp. 841-853
Open Access | Times Cited: 19
Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force
Siobhan Botwright, Manit Sittimart, Kinanti Khansa Chavarina, et al.
Value in Health (2025)
Closed Access
Multiple Perspectives on the Need for Real‐World Evidence to Inform Regulatory and Health Technology Assessment Decision‐Making: Scoping Review and Stakeholder Interviews
Marieke S. Jansen, Olaf M. Dekkers, Saskia le Cessie, et al.
Pharmacoepidemiology and Drug Safety (2025) Vol. 34, Iss. 1
Open Access
Comparative effectiveness of laparoscopic versus open colectomy in colon cancer patients: a study protocol for emulating a target trial using cancer registry data
Semaw Ferede Abera, Gabriele Robers, Anika Kästner, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 1
Open Access
An integrated framework to guide evidence-informed public health policymaking
Michelle M. Haby, Ludovic Revéiz, Rebekah Thomas, et al.
Journal of Public Health Policy (2025)
Open Access
Beyond money: A social burden framework to enhance resilience valuation for tribal communities in the United States
Olga Epshtein Hart, Amanda Wachtel, Katherine Jones, et al.
Energy Research & Social Science (2025) Vol. 120, pp. 103934-103934
Closed Access
Evaluating the Effectiveness of Assisted Oocyte Activation in ICSI: Pairwise Meta‐Analyses and Systematic Evidence Evaluation
Mohamed Fawzy, Mohamad AlaaEldein Elsuity, Yasmin Magdi, et al.
BJOG An International Journal of Obstetrics & Gynaecology (2025)
Closed Access
Evolving Recommendations for Patient Populations Among Oncology Medicines: A Quantitative and Qualitative Analysis
Milou A. Hogervorst, Rick A. Vreman, Theresa Oduol, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider’s story
Charles Gore, Sébastien Morin, John‐Arne Røttingen, et al.
BMJ Global Health (2023) Vol. 8, Iss. 9, pp. e012964-e012964
Open Access | Times Cited: 14
A systematic review of full economic evaluations of robotic-assisted surgery in thoracic and abdominopelvic procedures
Hamid Sadri, Michael Fung‐Kee‐Fung, Bobby Shayegan, et al.
Journal of Robotic Surgery (2023) Vol. 17, Iss. 6, pp. 2671-2685
Open Access | Times Cited: 13
Perspectives on how to build bridges between regulation, health technology assessment and clinical guideline development: a qualitative focus group study with European experts
Milou A. Hogervorst, Mathias Møllebæk, Rick A. Vreman, et al.
BMJ Open (2023) Vol. 13, Iss. 8, pp. e072309-e072309
Open Access | Times Cited: 12
Analytical Methods for Comparing Uncontrolled Trials with External Controls from Real-World Data: a Systematic Literature Review and Comparison to European Regulatory and Health Technology Assessment Practice
Milou A. Hogervorst, Kanaka V Soman, Helga Gardarsdóttir, et al.
Value in Health (2024)
Open Access | Times Cited: 3
Drug interference with biochemical laboratory tests
Bojan Stanimirov, Vanesa Sekeruš, Maja Đanić, et al.
Biochemia Medica (2023) Vol. 33, Iss. 2, pp. 123-131
Open Access | Times Cited: 9
User-experience testing of an evidence-to-decision framework for selecting essential medicines
Thomas Piggott, Lorenzo Moja, Carlos A. Cuello‐García, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 1, pp. e0002723-e0002723
Open Access | Times Cited: 2
Healthcare decision-making for tumour-agnostic therapies in Europe: lessons learned
Milou A. Hogervorst, Christine C. van Hattem, Gabe S. Sonke, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104031-104031
Open Access | Times Cited: 2
ROBVALU: a tool for assessing risk of bias in studies about people’s values, utilities, or importance of health outcomes
Samer G. Karam, Yuan Zhang, Héctor Pardo‐Hernández, et al.
BMJ (2024), pp. e079890-e079890
Open Access | Times Cited: 2
WHO Model list of essential medicines: visions for the future
Thomas Piggott, Lorenzo Moja, Benedikt Huttner, et al.
Bulletin of the World Health Organization (2024) Vol. 102, Iss. 10, pp. 722-729
Open Access | Times Cited: 2
Mapping theories, models and frameworks to implement or evaluate digital health interventions: A scoping review. (Preprint)
Geneviève Rouleau, Kelly Wu, Karishini Ramamoorthi, et al.
Journal of Medical Internet Research (2023) Vol. 26, pp. e51098-e51098
Open Access | Times Cited: 7
Evidence uptake is only part of the process: Stakeholders’ insights on WHO treatment guideline recommendation processes for radical cure of P. vivax malaria
Varunika Ruwanpura, Koen Peeters Grietens, Ric N. Price, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 3, pp. e0002990-e0002990
Open Access | Times Cited: 2
Enhancing Patient Satisfaction in Cross-Regional Healthcare: a Cross-Sectional Study in the Knowledge-Based Healthcare Landscape
Li Li, Cui Xin, Wei Feng
Journal of the Knowledge Economy (2023) Vol. 15, Iss. 3, pp. 14172-14198
Open Access | Times Cited: 6
Decision criteria for selecting essential medicines and their connection to guidelines: an interpretive descriptive qualitative interview study
Thomas Piggott, Lorenzo Moja, Elie A. Akl, et al.
Journal of Clinical Epidemiology (2022) Vol. 154, pp. 146-155
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top